サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1390559

バイオマーカー技術市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Biomarker Technologies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 149 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
バイオマーカー技術市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年11月24日
発行: IMARC
ページ情報: 英文 149 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

バイオマーカー技術の世界市場規模は2022年に354億米ドルに達しました。今後、IMARC Groupは、同市場が2028年までに759億米ドルに達し、2022～2028年の成長率（CAGR）は13.56%に達すると予測しています。

バイオマーカー技術は、デオキシリボ核酸（DNA）やリボ核酸（RNA）などの遺伝子バイオマーカーに依存して病原体を検出する、信頼性が高く費用対効果の高い検出ツールです。これらの技術は、さまざまな病気や障害の早期診断に幅広く応用されています。また、創薬・開発プロセスや神経系疾患、心血管疾患、感染症、免疫・遺伝疾患、がんの管理にも利用されています。一般的に使用されるバイオマーカー技術には、ポリメラーゼ連鎖反応（PCR）、次世代シーケンシング（NGS）、免疫測定などがあります。

バイオマーカー技術の市場動向：

現在、世界中でがんや心血管疾患、神経疾患、自己免疫疾患を患う人の数が大幅に増加しています。このことは、早期かつ効果的な診断に対する需要の高まりと相まって、市場にプラスの影響を与えている主な要因の1つとなっています。これとは別に、老人人口の増加も市場の成長に寄与しています。さらに、各国の政府機関による創薬のための研究開発（R&D）資金が増加しています。これに加えて、特に新興国ではヘルスケアインフラが大幅に拡大しており、市場の成長を後押ししています。さらに、市場をリードする企業は、正確な患者層別化を提供するバイオマーカー技術に数多くの進歩を導入しています。また、デジタル機器を使用することで、客観的、定量的、生理学的、行動学的データの収集を支援するデジタルバイオマーカーを開発しています。これらのデジタルバイオマーカーは、ビッグデータ分析、統合意思決定のための人工知能（AI）、機械学習（ML）ソリューションとも組み合わされています。より良い治療のためのがんの早期発見に対する意識の高まりや、個人の所得水準の急上昇など、その他の主な要因も市場成長を後押しすると予測されています。

本レポートで扱う主な質問

  • 世界のバイオマーカー技術市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • COVID-19が世界のバイオマーカー技術市場に与えた影響は？
  • 主要な地域市場は？
  • 検査タイプ別の市場内訳は？
  • 適応症別の市場内訳は？
  • 製品別の市場内訳は？
  • 技術別の市場内訳は？
  • 用途別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主要な促進要因と課題は何か？
  • 世界のバイオマーカー技術市場の構造と主要プレーヤーは？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界のバイオマーカー技術市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：検査タイプ別

  • 固形生検
    • 市場動向
    • 市場予測
  • リキッドバイオプシー
    • 市場動向
    • 市場予測

第7章 市場内訳：適応症別

  • がん
    • 市場動向
    • 市場予測
  • 感染症
    • 市場動向
    • 市場予測
  • 自己免疫疾患
    • 市場動向
    • 市場予測
  • 心血管疾患
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：製品別

  • 消耗品
    • 市場動向
    • 市場予測
  • アッセイ
    • 市場動向
    • 市場予測
  • 試薬
    • 市場動向
    • 市場予測
  • 機器
    • 市場動向
    • 市場予測

第9章 市場内訳：技術別

  • ポリメラーゼ連鎖反応（PCR）
    • 市場動向
    • 市場予測
  • 次世代シーケンサー（NGS）
    • 市場動向
    • 市場予測
  • 免疫測定
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳：用途別

  • 創薬
    • 市場動向
    • 市場予測
  • 臨床診断
    • 市場動向
    • 市場予測
  • 個別化医療
    • 市場動向
    • 市場予測

第11章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第12章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第15章 価格分析

第16章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Agilent Technologies Inc.
    • Bio-Rad Laboratories Inc.
    • Danaher Corporation
    • F. Hoffmann-La Roche AG
    • Illumina Inc.
    • LI-COR Inc.
    • Merck KGaA
    • PerkinElmer Inc.
    • QIAGEN N.V.
    • Shimadzu Corporation
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
図表

List of Figures

  • Figure 1: Global: Biomarker Technologies Market: Major Drivers and Challenges
  • Figure 2: Global: Biomarker Technologies Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Biomarker Technologies Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Biomarker Technologies Market: Breakup by Test Type (in %), 2022
  • Figure 5: Global: Biomarker Technologies Market: Breakup by Indication (in %), 2022
  • Figure 6: Global: Biomarker Technologies Market: Breakup by Product (in %), 2022
  • Figure 7: Global: Biomarker Technologies Market: Breakup by Technology (in %), 2022
  • Figure 8: Global: Biomarker Technologies Market: Breakup by Application (in %), 2022
  • Figure 9: Global: Biomarker Technologies Market: Breakup by Region (in %), 2022
  • Figure 10: Global: Biomarker Technologies (Solid Biopsy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Biomarker Technologies (Solid Biopsy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Biomarker Technologies (Liquid Biopsy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Biomarker Technologies (Liquid Biopsy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Biomarker Technologies (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Biomarker Technologies (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Biomarker Technologies (Infectious Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Biomarker Technologies (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Biomarker Technologies (Autoimmune Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Biomarker Technologies (Autoimmune Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Biomarker Technologies (Cardiovascular Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Biomarker Technologies (Cardiovascular Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Biomarker Technologies (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Biomarker Technologies (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Biomarker Technologies (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Biomarker Technologies (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Biomarker Technologies (Assay) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Biomarker Technologies (Assay) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Biomarker Technologies (Reagent) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Biomarker Technologies (Reagent) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Biomarker Technologies (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Biomarker Technologies (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Biomarker Technologies (Polymerase Chain Reaction - PCR) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Biomarker Technologies (Polymerase Chain Reaction - PCR) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Biomarker Technologies (Next Generation Sequencing - NGS) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Biomarker Technologies (Next Generation Sequencing - NGS) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Global: Biomarker Technologies (Immunoassay) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Global: Biomarker Technologies (Immunoassay) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Global: Biomarker Technologies (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Global: Biomarker Technologies (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Global: Biomarker Technologies (Drug Discovery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Global: Biomarker Technologies (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Global: Biomarker Technologies (Clinical Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Global: Biomarker Technologies (Clinical Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Global: Biomarker Technologies (Personalized Medicine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Global: Biomarker Technologies (Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: North America: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: North America: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: United States: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: United States: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Canada: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Canada: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Asia-Pacific: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Asia-Pacific: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: China: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: China: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Japan: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Japan: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: India: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: India: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: South Korea: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: South Korea: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Australia: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Australia: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Indonesia: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Indonesia: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Others: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Others: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Europe: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Europe: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Germany: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Germany: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: France: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: France: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: United Kingdom: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: United Kingdom: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Italy: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Italy: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Spain: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Spain: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Russia: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Russia: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Others: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Others: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Latin America: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 85: Latin America: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Brazil: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 87: Brazil: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 88: Mexico: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 89: Mexico: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 90: Others: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 91: Others: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 92: Middle East and Africa: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 93: Middle East and Africa: Biomarker Technologies Market: Breakup by Country (in %), 2022
  • Figure 94: Middle East and Africa: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 95: Global: Biomarker Technologies Industry: SWOT Analysis
  • Figure 96: Global: Biomarker Technologies Industry: Value Chain Analysis
  • Figure 97: Global: Biomarker Technologies Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biomarker Technologies Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Biomarker Technologies Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
  • Table 3: Global: Biomarker Technologies Market Forecast: Breakup by Indication (in Million US$), 2023-2028
  • Table 4: Global: Biomarker Technologies Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 5: Global: Biomarker Technologies Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 6: Global: Biomarker Technologies Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 7: Global: Biomarker Technologies Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 8: Global: Biomarker Technologies Market: Competitive Structure
  • Table 9: Global: Biomarker Technologies Market: Key Players
目次
Product Code: SR112023A4341

Abstract

The global biomarker technologies market size reached US$ 35.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 75.9 Billion by 2028, exhibiting a growth rate (CAGR) of 13.56% during 2022-2028.

Biomarker technologies are reliable and cost-effective detection tools that rely on genetic biomarkers, such as deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), for detecting pathogens. These technologies find extensive application in the early diagnosis of different diseases and disorders. They are also utilized in the drug discovery and development processes and the management of nervous system disorders, cardiovascular diseases, infections, immunological and genetic disorders, and cancer. Some of the commonly used biomarker technologies include polymerase chain reaction (PCR), next-generation sequencing (NGS) and immunoassay.

Biomarker Technologies Market Trends:

There is currently a considerable rise in the number of individuals who are suffering from cancer and cardiovascular, neurological, and autoimmune diseases across the globe. This, coupled with the escalating demand for early and effective diagnosis, represents one of the key factors positively influencing the market. Apart from this, the rising geriatric population is also contributing to the growth of the market. Moreover, there is an increase in research and development (R&D) funding for drug discovery by governing agencies of numerous countries. This, along with the considerably expanding healthcare infrastructure, especially in developing countries, is propelling the market growth. Furthermore, leading market players are introducing numerous advancements in biomarker technologies that provide accurate patient stratification. They are also developing digital biomarkers that aid in collecting objective, quantifiable, physiological, and behavioral data by using digital devices. These digital biomarkers are also incorporated with artificial intelligence (AI), machine learning (ML) solutions for big data analysis, and integrated decision making. Other major factors, including rising awareness about the early detection of cancer for better treatment, and surging income levels of individuals, are projected to impel the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global biomarker technologies market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on test type, indication, product, technology and application.

Breakup by Test Type:

Solid Biopsy

Liquid Biopsy

Breakup by Indication:

Cancer

Infectious Diseases

Autoimmune Disorders

Cardiovascular Disorders

Others

Breakup by Product:

Consumables

Assay

Reagent

Instruments

Breakup by Technology:

Polymerase Chain Reaction (PCR)

Next Generation Sequencing (NGS)

Immunoassay

Others

Breakup by Application:

Drug Discovery

Clinical Diagnostics

Personalized Medicine

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Illumina Inc., LI-COR Inc., Merck KGaA, PerkinElmer Inc., QIAGEN N.V., Shimadzu Corporation, Thermo Fisher Scientific Inc. and Waters Corporation.

Key Questions Answered in This Report:

  • How has the global biomarker technologies market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global biomarker technologies market?
  • What are the key regional markets?
  • What is the breakup of the market based on the test type?
  • What is the breakup of the market based on the indication?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global biomarker technologies market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biomarker Technologies Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test Type

  • 6.1 Solid Biopsy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Liquid Biopsy
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Infectious Diseases
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Autoimmune Disorders
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cardiovascular Disorders
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Product

  • 8.1 Consumables
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Assay
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Reagent
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Instruments
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Technology

  • 9.1 Polymerase Chain Reaction (PCR)
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Next Generation Sequencing (NGS)
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Immunoassay
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Application

  • 10.1 Drug Discovery
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Clinical Diagnostics
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Personalized Medicine
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Agilent Technologies Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Bio-Rad Laboratories Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 Danaher Corporation
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 F. Hoffmann-La Roche AG
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
    • 16.3.5 Illumina Inc.
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 LI-COR Inc.
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Merck KGaA
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 PerkinElmer Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 QIAGEN N.V.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Shimadzu Corporation
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
      • 16.3.10.4 SWOT Analysis
    • 16.3.11 Thermo Fisher Scientific Inc.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
      • 16.3.11.4 SWOT Analysis
    • 16.3.12 Waters Corporation
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis